nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—breast cancer	0.417	0.63	CbGaD
Pralidoxime—BCHE—breast cancer	0.245	0.37	CbGaD
Pralidoxime—ACHE—Irinotecan—breast cancer	0.115	0.624	CbGbCtD
Pralidoxime—BCHE—Irinotecan—breast cancer	0.0691	0.376	CbGbCtD
Pralidoxime—Muscle necrosis—Melphalan—breast cancer	0.022	0.219	CcSEcCtD
Pralidoxime—Inflammation—Fulvestrant—breast cancer	0.0021	0.0209	CcSEcCtD
Pralidoxime—Inflammation—Anastrozole—breast cancer	0.00162	0.0161	CcSEcCtD
Pralidoxime—Haemoglobin—Fluoxymesterone—breast cancer	0.00158	0.0157	CcSEcCtD
Pralidoxime—Haemorrhage—Fluoxymesterone—breast cancer	0.00157	0.0156	CcSEcCtD
Pralidoxime—Diplopia—Toremifene—breast cancer	0.00146	0.0145	CcSEcCtD
Pralidoxime—Inflammation—Tamoxifen—breast cancer	0.00111	0.011	CcSEcCtD
Pralidoxime—Muscular weakness—Ixabepilone—breast cancer	0.00107	0.0106	CcSEcCtD
Pralidoxime—Haemoglobin—Fulvestrant—breast cancer	0.00103	0.0102	CcSEcCtD
Pralidoxime—Haemorrhage—Fulvestrant—breast cancer	0.00102	0.0102	CcSEcCtD
Pralidoxime—Haemoglobin—Exemestane—breast cancer	0.000894	0.00888	CcSEcCtD
Pralidoxime—Haemorrhage—Exemestane—breast cancer	0.00089	0.00884	CcSEcCtD
Pralidoxime—Haemoglobin—Ixabepilone—breast cancer	0.000844	0.00838	CcSEcCtD
Pralidoxime—Haemorrhage—Ixabepilone—breast cancer	0.000839	0.00834	CcSEcCtD
Pralidoxime—Vision blurred—Toremifene—breast cancer	0.000829	0.00824	CcSEcCtD
Pralidoxime—Haemoglobin—Anastrozole—breast cancer	0.000795	0.00789	CcSEcCtD
Pralidoxime—Haemoglobin—Letrozole—breast cancer	0.000795	0.00789	CcSEcCtD
Pralidoxime—Haemorrhage—Anastrozole—breast cancer	0.000791	0.00785	CcSEcCtD
Pralidoxime—Haemorrhage—Letrozole—breast cancer	0.000791	0.00785	CcSEcCtD
Pralidoxime—Haemoglobin—Idarubicin—breast cancer	0.000754	0.00749	CcSEcCtD
Pralidoxime—Inflammation—Fluorouracil—breast cancer	0.00075	0.00745	CcSEcCtD
Pralidoxime—Haemorrhage—Idarubicin—breast cancer	0.00075	0.00745	CcSEcCtD
Pralidoxime—Pain—Carboplatin—breast cancer	0.000718	0.00713	CcSEcCtD
Pralidoxime—Headache—Fluoxymesterone—breast cancer	0.000698	0.00693	CcSEcCtD
Pralidoxime—Nausea—Fluoxymesterone—breast cancer	0.000662	0.00657	CcSEcCtD
Pralidoxime—Vision blurred—Letrozole—breast cancer	0.000649	0.00644	CcSEcCtD
Pralidoxime—Pain—Fulvestrant—breast cancer	0.000622	0.00618	CcSEcCtD
Pralidoxime—Pain—Toremifene—breast cancer	0.000614	0.0061	CcSEcCtD
Pralidoxime—Muscular weakness—Vinorelbine—breast cancer	0.00059	0.00586	CcSEcCtD
Pralidoxime—Drowsiness—Goserelin—breast cancer	0.000576	0.00572	CcSEcCtD
Pralidoxime—Haemoglobin—Vinblastine—breast cancer	0.00056	0.00556	CcSEcCtD
Pralidoxime—Haemorrhage—Vinblastine—breast cancer	0.000557	0.00553	CcSEcCtD
Pralidoxime—Tachycardia—Letrozole—breast cancer	0.000548	0.00544	CcSEcCtD
Pralidoxime—Haemoglobin—Tamoxifen—breast cancer	0.000544	0.0054	CcSEcCtD
Pralidoxime—Inflammation—Docetaxel—breast cancer	0.000542	0.00538	CcSEcCtD
Pralidoxime—Haemorrhage—Tamoxifen—breast cancer	0.000541	0.00537	CcSEcCtD
Pralidoxime—Pain—Exemestane—breast cancer	0.000541	0.00537	CcSEcCtD
Pralidoxime—Haemoglobin—Melphalan—breast cancer	0.000532	0.00529	CcSEcCtD
Pralidoxime—Haemorrhage—Melphalan—breast cancer	0.00053	0.00526	CcSEcCtD
Pralidoxime—Inflammation—Capecitabine—breast cancer	0.000524	0.00521	CcSEcCtD
Pralidoxime—Haemoglobin—Goserelin—breast cancer	0.000519	0.00516	CcSEcCtD
Pralidoxime—Haemorrhage—Goserelin—breast cancer	0.000517	0.00513	CcSEcCtD
Pralidoxime—Hyperventilation—Epirubicin—breast cancer	0.000515	0.00511	CcSEcCtD
Pralidoxime—Pain—Ixabepilone—breast cancer	0.00051	0.00507	CcSEcCtD
Pralidoxime—Somnolence—Letrozole—breast cancer	0.000499	0.00496	CcSEcCtD
Pralidoxime—Somnolence—Anastrozole—breast cancer	0.000499	0.00496	CcSEcCtD
Pralidoxime—Headache—Lapatinib—breast cancer	0.000496	0.00492	CcSEcCtD
Pralidoxime—Agitation—Chlorambucil—breast cancer	0.000486	0.00483	CcSEcCtD
Pralidoxime—Dizziness—Fulvestrant—breast cancer	0.000481	0.00478	CcSEcCtD
Pralidoxime—Pain—Anastrozole—breast cancer	0.00048	0.00477	CcSEcCtD
Pralidoxime—Pain—Letrozole—breast cancer	0.00048	0.00477	CcSEcCtD
Pralidoxime—Hyperventilation—Doxorubicin—breast cancer	0.000476	0.00473	CcSEcCtD
Pralidoxime—Dizziness—Toremifene—breast cancer	0.000475	0.00472	CcSEcCtD
Pralidoxime—Nausea—Lapatinib—breast cancer	0.00047	0.00467	CcSEcCtD
Pralidoxime—Muscular weakness—Fluorouracil—breast cancer	0.000466	0.00463	CcSEcCtD
Pralidoxime—Headache—Fulvestrant—breast cancer	0.000456	0.00453	CcSEcCtD
Pralidoxime—Pain—Raloxifene—breast cancer	0.000456	0.00453	CcSEcCtD
Pralidoxime—Headache—Toremifene—breast cancer	0.00045	0.00447	CcSEcCtD
Pralidoxime—Haemoglobin—Thiotepa—breast cancer	0.000444	0.00441	CcSEcCtD
Pralidoxime—Haemorrhage—Thiotepa—breast cancer	0.000442	0.00439	CcSEcCtD
Pralidoxime—Nausea—Fulvestrant—breast cancer	0.000432	0.00429	CcSEcCtD
Pralidoxime—Nausea—Toremifene—breast cancer	0.000427	0.00424	CcSEcCtD
Pralidoxime—Drowsiness—Mitoxantrone—breast cancer	0.000425	0.00422	CcSEcCtD
Pralidoxime—Vision blurred—Goserelin—breast cancer	0.000424	0.00421	CcSEcCtD
Pralidoxime—Dizziness—Exemestane—breast cancer	0.000418	0.00415	CcSEcCtD
Pralidoxime—Muscular weakness—Paclitaxel—breast cancer	0.000397	0.00394	CcSEcCtD
Pralidoxime—Headache—Exemestane—breast cancer	0.000396	0.00393	CcSEcCtD
Pralidoxime—Dizziness—Ixabepilone—breast cancer	0.000394	0.00392	CcSEcCtD
Pralidoxime—Inflammation—Methotrexate—breast cancer	0.00039	0.00388	CcSEcCtD
Pralidoxime—Haemoglobin—Mitoxantrone—breast cancer	0.000384	0.00381	CcSEcCtD
Pralidoxime—Haemoglobin—Irinotecan—breast cancer	0.000384	0.00381	CcSEcCtD
Pralidoxime—Haemorrhage—Mitoxantrone—breast cancer	0.000382	0.00379	CcSEcCtD
Pralidoxime—Haemorrhage—Irinotecan—breast cancer	0.000382	0.00379	CcSEcCtD
Pralidoxime—Nausea—Exemestane—breast cancer	0.000375	0.00373	CcSEcCtD
Pralidoxime—Haemoglobin—Gemcitabine—breast cancer	0.000374	0.00371	CcSEcCtD
Pralidoxime—Headache—Ixabepilone—breast cancer	0.000374	0.00371	CcSEcCtD
Pralidoxime—Haemorrhage—Gemcitabine—breast cancer	0.000372	0.00369	CcSEcCtD
Pralidoxime—Dizziness—Letrozole—breast cancer	0.000371	0.00369	CcSEcCtD
Pralidoxime—Dizziness—Anastrozole—breast cancer	0.000371	0.00369	CcSEcCtD
Pralidoxime—Diplopia—Capecitabine—breast cancer	0.000369	0.00367	CcSEcCtD
Pralidoxime—Pain—Chlorambucil—breast cancer	0.000369	0.00367	CcSEcCtD
Pralidoxime—Haemoglobin—Fluorouracil—breast cancer	0.000367	0.00365	CcSEcCtD
Pralidoxime—Tachycardia—Melphalan—breast cancer	0.000367	0.00365	CcSEcCtD
Pralidoxime—Haemorrhage—Fluorouracil—breast cancer	0.000366	0.00363	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—breast cancer	0.000365	0.00363	CcSEcCtD
Pralidoxime—Vision blurred—Thiotepa—breast cancer	0.000363	0.0036	CcSEcCtD
Pralidoxime—Tachycardia—Goserelin—breast cancer	0.000358	0.00356	CcSEcCtD
Pralidoxime—Nausea—Ixabepilone—breast cancer	0.000354	0.00352	CcSEcCtD
Pralidoxime—Agitation—Thiotepa—breast cancer	0.000354	0.00351	CcSEcCtD
Pralidoxime—Dizziness—Raloxifene—breast cancer	0.000352	0.0035	CcSEcCtD
Pralidoxime—Headache—Anastrozole—breast cancer	0.000352	0.00349	CcSEcCtD
Pralidoxime—Headache—Letrozole—breast cancer	0.000352	0.00349	CcSEcCtD
Pralidoxime—Pain—Vinblastine—breast cancer	0.000338	0.00336	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—breast cancer	0.000338	0.00336	CcSEcCtD
Pralidoxime—Headache—Raloxifene—breast cancer	0.000334	0.00332	CcSEcCtD
Pralidoxime—Headache—Idarubicin—breast cancer	0.000334	0.00332	CcSEcCtD
Pralidoxime—Nausea—Anastrozole—breast cancer	0.000334	0.00331	CcSEcCtD
Pralidoxime—Nausea—Letrozole—breast cancer	0.000334	0.00331	CcSEcCtD
Pralidoxime—Pain—Tamoxifen—breast cancer	0.000329	0.00326	CcSEcCtD
Pralidoxime—Somnolence—Goserelin—breast cancer	0.000326	0.00324	CcSEcCtD
Pralidoxime—Muscular weakness—Capecitabine—breast cancer	0.000326	0.00323	CcSEcCtD
Pralidoxime—Pain—Melphalan—breast cancer	0.000322	0.0032	CcSEcCtD
Pralidoxime—Tachycardia—Vinorelbine—breast cancer	0.000321	0.00319	CcSEcCtD
Pralidoxime—Nausea—Raloxifene—breast cancer	0.000317	0.00314	CcSEcCtD
Pralidoxime—Nausea—Idarubicin—breast cancer	0.000317	0.00314	CcSEcCtD
Pralidoxime—Pain—Goserelin—breast cancer	0.000314	0.00312	CcSEcCtD
Pralidoxime—Vision blurred—Mitoxantrone—breast cancer	0.000313	0.00311	CcSEcCtD
Pralidoxime—Haemoglobin—Paclitaxel—breast cancer	0.000313	0.00311	CcSEcCtD
Pralidoxime—Haemorrhage—Paclitaxel—breast cancer	0.000311	0.00309	CcSEcCtD
Pralidoxime—Tachycardia—Thiotepa—breast cancer	0.000306	0.00304	CcSEcCtD
Pralidoxime—Vision blurred—Fluorouracil—breast cancer	0.0003	0.00298	CcSEcCtD
Pralidoxime—Pain—Vinorelbine—breast cancer	0.000281	0.00279	CcSEcCtD
Pralidoxime—Somnolence—Thiotepa—breast cancer	0.000279	0.00277	CcSEcCtD
Pralidoxime—Pain—Thiotepa—breast cancer	0.000269	0.00267	CcSEcCtD
Pralidoxime—Haemoglobin—Docetaxel—breast cancer	0.000265	0.00263	CcSEcCtD
Pralidoxime—Tachycardia—Mitoxantrone—breast cancer	0.000265	0.00263	CcSEcCtD
Pralidoxime—Haemorrhage—Docetaxel—breast cancer	0.000264	0.00262	CcSEcCtD
Pralidoxime—Dizziness—Vinblastine—breast cancer	0.000262	0.0026	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—breast cancer	0.000257	0.00255	CcSEcCtD
Pralidoxime—Haemoglobin—Capecitabine—breast cancer	0.000257	0.00255	CcSEcCtD
Pralidoxime—Nausea—Chlorambucil—breast cancer	0.000256	0.00255	CcSEcCtD
Pralidoxime—Haemorrhage—Capecitabine—breast cancer	0.000255	0.00254	CcSEcCtD
Pralidoxime—Vision blurred—Paclitaxel—breast cancer	0.000255	0.00254	CcSEcCtD
Pralidoxime—Dizziness—Tamoxifen—breast cancer	0.000254	0.00252	CcSEcCtD
Pralidoxime—Tachycardia—Fluorouracil—breast cancer	0.000253	0.00252	CcSEcCtD
Pralidoxime—Agitation—Paclitaxel—breast cancer	0.000249	0.00247	CcSEcCtD
Pralidoxime—Headache—Vinblastine—breast cancer	0.000248	0.00246	CcSEcCtD
Pralidoxime—Dizziness—Goserelin—breast cancer	0.000243	0.00241	CcSEcCtD
Pralidoxime—Somnolence—Irinotecan—breast cancer	0.000241	0.00239	CcSEcCtD
Pralidoxime—Somnolence—Mitoxantrone—breast cancer	0.000241	0.00239	CcSEcCtD
Pralidoxime—Headache—Tamoxifen—breast cancer	0.000241	0.00239	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—breast cancer	0.000238	0.00236	CcSEcCtD
Pralidoxime—Nausea—Vinblastine—breast cancer	0.000235	0.00233	CcSEcCtD
Pralidoxime—Somnolence—Gemcitabine—breast cancer	0.000235	0.00233	CcSEcCtD
Pralidoxime—Pain—Mitoxantrone—breast cancer	0.000232	0.0023	CcSEcCtD
Pralidoxime—Pain—Irinotecan—breast cancer	0.000232	0.0023	CcSEcCtD
Pralidoxime—Somnolence—Fluorouracil—breast cancer	0.000231	0.00229	CcSEcCtD
Pralidoxime—Headache—Goserelin—breast cancer	0.00023	0.00228	CcSEcCtD
Pralidoxime—Nausea—Tamoxifen—breast cancer	0.000228	0.00227	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—breast cancer	0.000227	0.00225	CcSEcCtD
Pralidoxime—Pain—Gemcitabine—breast cancer	0.000226	0.00224	CcSEcCtD
Pralidoxime—Nausea—Melphalan—breast cancer	0.000224	0.00222	CcSEcCtD
Pralidoxime—Pain—Fluorouracil—breast cancer	0.000222	0.00221	CcSEcCtD
Pralidoxime—Nausea—Goserelin—breast cancer	0.000218	0.00217	CcSEcCtD
Pralidoxime—Dizziness—Vinorelbine—breast cancer	0.000217	0.00216	CcSEcCtD
Pralidoxime—Tachycardia—Paclitaxel—breast cancer	0.000216	0.00214	CcSEcCtD
Pralidoxime—Drowsiness—Methotrexate—breast cancer	0.000212	0.0021	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—breast cancer	0.00021	0.00208	CcSEcCtD
Pralidoxime—Vision blurred—Capecitabine—breast cancer	0.00021	0.00208	CcSEcCtD
Pralidoxime—Dizziness—Thiotepa—breast cancer	0.000208	0.00206	CcSEcCtD
Pralidoxime—Headache—Vinorelbine—breast cancer	0.000206	0.00205	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—breast cancer	0.000198	0.00197	CcSEcCtD
Pralidoxime—Headache—Thiotepa—breast cancer	0.000197	0.00195	CcSEcCtD
Pralidoxime—Somnolence—Paclitaxel—breast cancer	0.000197	0.00195	CcSEcCtD
Pralidoxime—Nausea—Vinorelbine—breast cancer	0.000195	0.00194	CcSEcCtD
Pralidoxime—Haemoglobin—Methotrexate—breast cancer	0.000191	0.0019	CcSEcCtD
Pralidoxime—Haemorrhage—Methotrexate—breast cancer	0.00019	0.00189	CcSEcCtD
Pralidoxime—Pain—Paclitaxel—breast cancer	0.000189	0.00188	CcSEcCtD
Pralidoxime—Nausea—Thiotepa—breast cancer	0.000187	0.00185	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—breast cancer	0.000183	0.00182	CcSEcCtD
Pralidoxime—Tachycardia—Docetaxel—breast cancer	0.000183	0.00182	CcSEcCtD
Pralidoxime—Dizziness—Irinotecan—breast cancer	0.000179	0.00178	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—breast cancer	0.000179	0.00178	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—breast cancer	0.000178	0.00177	CcSEcCtD
Pralidoxime—Tachycardia—Capecitabine—breast cancer	0.000177	0.00176	CcSEcCtD
Pralidoxime—Dizziness—Fluorouracil—breast cancer	0.000172	0.00171	CcSEcCtD
Pralidoxime—Headache—Mitoxantrone—breast cancer	0.00017	0.00169	CcSEcCtD
Pralidoxime—Headache—Irinotecan—breast cancer	0.00017	0.00169	CcSEcCtD
Pralidoxime—Somnolence—Docetaxel—breast cancer	0.000167	0.00165	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—breast cancer	0.000165	0.00164	CcSEcCtD
Pralidoxime—Headache—Gemcitabine—breast cancer	0.000165	0.00164	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—breast cancer	0.000165	0.00164	CcSEcCtD
Pralidoxime—Headache—Fluorouracil—breast cancer	0.000163	0.00162	CcSEcCtD
Pralidoxime—Nausea—Irinotecan—breast cancer	0.000161	0.0016	CcSEcCtD
Pralidoxime—Nausea—Mitoxantrone—breast cancer	0.000161	0.0016	CcSEcCtD
Pralidoxime—Pain—Docetaxel—breast cancer	0.00016	0.00159	CcSEcCtD
Pralidoxime—Nausea—Gemcitabine—breast cancer	0.000157	0.00156	CcSEcCtD
Pralidoxime—Vision blurred—Methotrexate—breast cancer	0.000156	0.00155	CcSEcCtD
Pralidoxime—Pain—Capecitabine—breast cancer	0.000155	0.00154	CcSEcCtD
Pralidoxime—Nausea—Fluorouracil—breast cancer	0.000154	0.00153	CcSEcCtD
Pralidoxime—Dizziness—Paclitaxel—breast cancer	0.000146	0.00145	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—breast cancer	0.000146	0.00145	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—breast cancer	0.000142	0.00141	CcSEcCtD
Pralidoxime—Headache—Paclitaxel—breast cancer	0.000139	0.00138	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—breast cancer	0.000135	0.00134	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—breast cancer	0.000132	0.00131	CcSEcCtD
Pralidoxime—Nausea—Paclitaxel—breast cancer	0.000131	0.0013	CcSEcCtD
Pralidoxime—Dizziness—Docetaxel—breast cancer	0.000124	0.00123	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—breast cancer	0.000123	0.00123	CcSEcCtD
Pralidoxime—Somnolence—Methotrexate—breast cancer	0.00012	0.00119	CcSEcCtD
Pralidoxime—Dizziness—Capecitabine—breast cancer	0.00012	0.00119	CcSEcCtD
Pralidoxime—Headache—Docetaxel—breast cancer	0.000117	0.00117	CcSEcCtD
Pralidoxime—Pain—Methotrexate—breast cancer	0.000116	0.00115	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—breast cancer	0.000114	0.00113	CcSEcCtD
Pralidoxime—Headache—Capecitabine—breast cancer	0.000114	0.00113	CcSEcCtD
Pralidoxime—Somnolence—Epirubicin—breast cancer	0.000112	0.00112	CcSEcCtD
Pralidoxime—Nausea—Docetaxel—breast cancer	0.000111	0.00111	CcSEcCtD
Pralidoxime—Pain—Epirubicin—breast cancer	0.000108	0.00107	CcSEcCtD
Pralidoxime—Nausea—Capecitabine—breast cancer	0.000108	0.00107	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—breast cancer	0.000104	0.00103	CcSEcCtD
Pralidoxime—Pain—Doxorubicin—breast cancer	0.0001	0.000993	CcSEcCtD
Pralidoxime—Dizziness—Methotrexate—breast cancer	8.93e-05	0.000887	CcSEcCtD
Pralidoxime—Headache—Methotrexate—breast cancer	8.46e-05	0.00084	CcSEcCtD
Pralidoxime—Dizziness—Epirubicin—breast cancer	8.36e-05	0.00083	CcSEcCtD
Pralidoxime—Nausea—Methotrexate—breast cancer	8.02e-05	0.000797	CcSEcCtD
Pralidoxime—Headache—Epirubicin—breast cancer	7.92e-05	0.000787	CcSEcCtD
Pralidoxime—Dizziness—Doxorubicin—breast cancer	7.74e-05	0.000768	CcSEcCtD
Pralidoxime—Nausea—Epirubicin—breast cancer	7.51e-05	0.000746	CcSEcCtD
Pralidoxime—Headache—Doxorubicin—breast cancer	7.33e-05	0.000728	CcSEcCtD
Pralidoxime—Nausea—Doxorubicin—breast cancer	6.95e-05	0.00069	CcSEcCtD
Pralidoxime—ACHE—Metabolism—ESRRA—breast cancer	4.65e-05	0.000884	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ANGPTL4—breast cancer	4.65e-05	0.000884	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	4.64e-05	0.000882	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLCO1B1—breast cancer	4.57e-05	0.000869	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A5—breast cancer	4.57e-05	0.000869	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTSD—breast cancer	4.54e-05	0.000863	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	4.52e-05	0.000859	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—THBS1—breast cancer	4.47e-05	0.00085	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	4.47e-05	0.000849	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	4.43e-05	0.000842	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	4.43e-05	0.000841	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APRT—breast cancer	4.42e-05	0.000839	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HADHB—breast cancer	4.41e-05	0.000838	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPI—breast cancer	4.41e-05	0.000838	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGFBP3—breast cancer	4.39e-05	0.000833	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BRAF—breast cancer	4.37e-05	0.00083	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—FASN—breast cancer	4.33e-05	0.000823	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	4.32e-05	0.00082	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	4.31e-05	0.000818	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACHE—breast cancer	4.28e-05	0.000813	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	4.27e-05	0.000812	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MDM2—breast cancer	4.26e-05	0.000809	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—RAF1—breast cancer	4.25e-05	0.000807	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	4.22e-05	0.000802	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDH1A1—breast cancer	4.21e-05	0.0008	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDH7A1—breast cancer	4.21e-05	0.0008	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—BCHE—breast cancer	4.18e-05	0.000794	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	4.17e-05	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	4.17e-05	0.000791	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	4.16e-05	0.00079	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ESRRA—breast cancer	4.15e-05	0.000789	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ANGPTL4—breast cancer	4.15e-05	0.000789	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS6—breast cancer	4.08e-05	0.000775	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	4.07e-05	0.000774	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTSD—breast cancer	4.05e-05	0.00077	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADSL—breast cancer	4.04e-05	0.000767	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FHL2—breast cancer	4.04e-05	0.000767	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NME1—breast cancer	4.04e-05	0.000767	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UMPS—breast cancer	4.04e-05	0.000767	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PHGDH—breast cancer	4.04e-05	0.000767	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—THBS1—breast cancer	3.99e-05	0.000758	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LDHB—breast cancer	3.96e-05	0.000752	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPSE—breast cancer	3.96e-05	0.000752	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BRIP1—breast cancer	3.96e-05	0.000752	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.95e-05	0.00075	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HADHB—breast cancer	3.94e-05	0.000748	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPI—breast cancer	3.94e-05	0.000748	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—BRAF—breast cancer	3.9e-05	0.00074	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TCF7L2—breast cancer	3.89e-05	0.000739	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	3.86e-05	0.000734	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—breast cancer	3.81e-05	0.000724	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.77e-05	0.000716	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	3.76e-05	0.000715	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDH7A1—breast cancer	3.76e-05	0.000713	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDH1A1—breast cancer	3.76e-05	0.000713	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA3—breast cancer	3.75e-05	0.000713	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMMR—breast cancer	3.75e-05	0.000713	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCC1—breast cancer	3.75e-05	0.000713	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.71e-05	0.000705	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MDM2—breast cancer	3.66e-05	0.000695	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—RAF1—breast cancer	3.65e-05	0.000693	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS6—breast cancer	3.64e-05	0.000692	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLAUR—breast cancer	3.64e-05	0.000691	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARGC1B—breast cancer	3.63e-05	0.00069	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FHL2—breast cancer	3.6e-05	0.000684	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UMPS—breast cancer	3.6e-05	0.000684	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NME1—breast cancer	3.6e-05	0.000684	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADSL—breast cancer	3.6e-05	0.000684	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PHGDH—breast cancer	3.6e-05	0.000684	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	3.56e-05	0.000676	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLG—breast cancer	3.55e-05	0.000675	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.54e-05	0.000672	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.54e-05	0.000672	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPSE—breast cancer	3.53e-05	0.000671	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LDHB—breast cancer	3.53e-05	0.000671	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—BRIP1—breast cancer	3.53e-05	0.000671	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TCF7L2—breast cancer	3.47e-05	0.000659	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	3.46e-05	0.000658	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	3.45e-05	0.000656	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA4—breast cancer	3.43e-05	0.000652	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA9—breast cancer	3.43e-05	0.000652	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—breast cancer	3.4e-05	0.000646	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.39e-05	0.000644	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	3.39e-05	0.000643	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.35e-05	0.000637	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCC1—breast cancer	3.35e-05	0.000636	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA3—breast cancer	3.35e-05	0.000636	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMMR—breast cancer	3.35e-05	0.000636	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX2—breast cancer	3.34e-05	0.000635	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA2—breast cancer	3.34e-05	0.000635	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX4—breast cancer	3.3e-05	0.000628	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SULT1A1—breast cancer	3.3e-05	0.000628	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MDM2—breast cancer	3.26e-05	0.00062	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—RAF1—breast cancer	3.25e-05	0.000618	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLAUR—breast cancer	3.24e-05	0.000616	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARGC1B—breast cancer	3.24e-05	0.000616	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—IDH1—breast cancer	3.23e-05	0.000613	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA1—breast cancer	3.23e-05	0.000613	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	3.22e-05	0.000613	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	3.2e-05	0.000608	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NAT2—breast cancer	3.19e-05	0.000606	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLG—breast cancer	3.17e-05	0.000602	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.16e-05	0.0006	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.16e-05	0.0006	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA9—breast cancer	3.06e-05	0.000582	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA4—breast cancer	3.06e-05	0.000582	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.02e-05	0.000574	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.99e-05	0.000568	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA2—breast cancer	2.98e-05	0.000567	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX2—breast cancer	2.98e-05	0.000567	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SULT1A1—breast cancer	2.95e-05	0.00056	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX4—breast cancer	2.95e-05	0.00056	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.94e-05	0.000558	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.88e-05	0.000548	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA1—breast cancer	2.88e-05	0.000547	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—IDH1—breast cancer	2.88e-05	0.000547	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NAT2—breast cancer	2.85e-05	0.000541	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.84e-05	0.00054	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MED12—breast cancer	2.8e-05	0.000531	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DPYD—breast cancer	2.8e-05	0.000531	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDOA—breast cancer	2.75e-05	0.000523	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA3—breast cancer	2.67e-05	0.000508	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A2—breast cancer	2.65e-05	0.000504	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.63e-05	0.000499	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HRAS—breast cancer	2.62e-05	0.000498	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CPT1A—breast cancer	2.6e-05	0.000494	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTR—breast cancer	2.6e-05	0.000494	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG2—breast cancer	2.6e-05	0.000494	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP1—breast cancer	2.6e-05	0.000494	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.57e-05	0.000489	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPGDS—breast cancer	2.55e-05	0.000484	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HBA1—breast cancer	2.53e-05	0.000481	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LEP—breast cancer	2.52e-05	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MED12—breast cancer	2.5e-05	0.000474	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DPYD—breast cancer	2.5e-05	0.000474	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTT1—breast cancer	2.47e-05	0.00047	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDOA—breast cancer	2.46e-05	0.000467	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.4e-05	0.000456	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA3—breast cancer	2.38e-05	0.000453	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A2—breast cancer	2.37e-05	0.00045	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.34e-05	0.000445	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP17A1—breast cancer	2.34e-05	0.000445	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HRAS—breast cancer	2.34e-05	0.000444	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTR—breast cancer	2.32e-05	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG2—breast cancer	2.32e-05	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CPT1A—breast cancer	2.32e-05	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP1—breast cancer	2.32e-05	0.000441	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO1—breast cancer	2.32e-05	0.00044	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS1—breast cancer	2.32e-05	0.00044	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.31e-05	0.000439	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.28e-05	0.000433	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPGDS—breast cancer	2.28e-05	0.000432	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2D6—breast cancer	2.27e-05	0.000432	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HBA1—breast cancer	2.26e-05	0.00043	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LEP—breast cancer	2.24e-05	0.000426	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA2—breast cancer	2.23e-05	0.000424	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTT1—breast cancer	2.21e-05	0.000419	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACHE—breast cancer	2.21e-05	0.000419	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FASN—breast cancer	2.16e-05	0.000411	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BCHE—breast cancer	2.15e-05	0.000409	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC5A5—breast cancer	2.13e-05	0.000404	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP17A1—breast cancer	2.09e-05	0.000397	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—breast cancer	2.08e-05	0.000395	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO1—breast cancer	2.07e-05	0.000393	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS1—breast cancer	2.07e-05	0.000393	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.06e-05	0.000391	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A1—breast cancer	2.06e-05	0.000391	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NQO1—breast cancer	2.06e-05	0.000391	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.03e-05	0.000386	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2D6—breast cancer	2.03e-05	0.000385	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.01e-05	0.000382	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—breast cancer	2.01e-05	0.000382	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HRAS—breast cancer	2.01e-05	0.000381	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP3A4—breast cancer	2e-05	0.000381	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.99e-05	0.000379	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA2—breast cancer	1.99e-05	0.000378	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1B1—breast cancer	1.97e-05	0.000374	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSP90AA1—breast cancer	1.93e-05	0.000367	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FASN—breast cancer	1.93e-05	0.000367	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC5A5—breast cancer	1.9e-05	0.000361	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA1—breast cancer	1.88e-05	0.000357	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—breast cancer	1.85e-05	0.000352	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—STK11—breast cancer	1.85e-05	0.000352	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP19A1—breast cancer	1.85e-05	0.000352	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NQO1—breast cancer	1.83e-05	0.000348	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A1—breast cancer	1.83e-05	0.000348	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.8e-05	0.000341	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—breast cancer	1.79e-05	0.000341	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HRAS—breast cancer	1.79e-05	0.00034	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP3A4—breast cancer	1.79e-05	0.00034	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.78e-05	0.000338	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1B1—breast cancer	1.76e-05	0.000334	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.74e-05	0.00033	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSP90AA1—breast cancer	1.72e-05	0.000328	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COMT—breast cancer	1.72e-05	0.000327	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—breast cancer	1.71e-05	0.000326	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—breast cancer	1.69e-05	0.000321	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ITPR1—breast cancer	1.69e-05	0.000321	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA1—breast cancer	1.68e-05	0.000319	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—breast cancer	1.67e-05	0.000318	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP19A1—breast cancer	1.65e-05	0.000314	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—STK11—breast cancer	1.65e-05	0.000314	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—breast cancer	1.62e-05	0.000308	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TYMS—breast cancer	1.59e-05	0.000303	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOR1—breast cancer	1.58e-05	0.000299	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—breast cancer	1.58e-05	0.000299	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLA2G4A—breast cancer	1.58e-05	0.000299	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.55e-05	0.000295	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTNNB1—breast cancer	1.54e-05	0.000293	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COMT—breast cancer	1.54e-05	0.000292	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—breast cancer	1.53e-05	0.000291	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX1—breast cancer	1.51e-05	0.000287	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—breast cancer	1.51e-05	0.000287	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ITPR1—breast cancer	1.51e-05	0.000286	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1A1—breast cancer	1.49e-05	0.000284	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—breast cancer	1.49e-05	0.000283	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ERCC2—breast cancer	1.48e-05	0.000281	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—breast cancer	1.45e-05	0.000275	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TYMS—breast cancer	1.42e-05	0.00027	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOR1—breast cancer	1.41e-05	0.000267	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—breast cancer	1.41e-05	0.000267	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLA2G4A—breast cancer	1.41e-05	0.000267	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—breast cancer	1.39e-05	0.000265	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTNNB1—breast cancer	1.38e-05	0.000261	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX1—breast cancer	1.35e-05	0.000256	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1A1—breast cancer	1.33e-05	0.000253	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ERCC2—breast cancer	1.32e-05	0.000251	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAV1—breast cancer	1.28e-05	0.000244	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—breast cancer	1.24e-05	0.000236	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.23e-05	0.000233	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—breast cancer	1.17e-05	0.000222	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAV1—breast cancer	1.15e-05	0.000218	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.09e-05	0.000208	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—breast cancer	1.04e-05	0.000198	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CD—breast cancer	1.03e-05	0.000195	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—breast cancer	1.02e-05	0.000193	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—breast cancer	9.71e-06	0.000185	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CD—breast cancer	9.17e-06	0.000174	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—breast cancer	9.06e-06	0.000172	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CB—breast cancer	8.96e-06	0.00017	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—breast cancer	8.88e-06	0.000169	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—breast cancer	8.66e-06	0.000165	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CB—breast cancer	8e-06	0.000152	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—breast cancer	7.92e-06	0.000151	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTEN—breast cancer	7.75e-06	0.000147	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTEN—breast cancer	6.91e-06	0.000131	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—breast cancer	5.46e-06	0.000104	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—breast cancer	4.88e-06	9.26e-05	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—breast cancer	4.46e-06	8.48e-05	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—breast cancer	3.98e-06	7.57e-05	CbGpPWpGaD
